TABLE 2.
Group | Activities | Concentrations of copper(µg/dl) | |
---|---|---|---|
ALT(U/L) | AST(U/L) | ||
Normal | 22.80 ± 9.91 | 55.62 ± 19.59 | 46.76 ± 4.63 |
HLD | 69.50 ± 62.47 a | 105.50 ± 51.26 a | 106.10 ± 15.69 a |
Amiloride | 28.14 ± 13.43 b | 54.71 ± 15.79 b | 63.17 ± 5.33 b |
PCA | 27.00 ± 14.32 b | 49.86 ± 14.30 b | 63.17 ± 5.33 b |
Represents a statistically significant difference from the control group (p < 0.01, respectively).
Represents a statistically significant difference between the drug administration group and the modeling group, respectively, (p < 0.01).